Esquire Financial holder plans $127K stock sale

Esquire Financial Holdings, Inc. (ESQ) received a notice under Rule 144 that Andrew C. Sagliocca plans to sell 10,000 shares of its common stock.

Rhea-AI Filing Summary

Esquire Financial Holdings, Inc. (ESQ) received a notice under Rule 144 that Andrew C. Sagliocca plans to sell 10,000 shares of its common stock. The filing lists an aggregate market value of $127,303.30 for these shares, with 12,094,583 shares outstanding and an approximate sale date of September 18, 2026. The seller previously received an RSA Stock Grant of 298,798 shares on December 16, 2024.

Key Figures

Shares to be sold: 10,000 shares Aggregate market value: $127,303.30 Shares outstanding: 12,094,583 shares +2 more

5 metrics

Shares to be sold 10,000 shares Planned Rule 144 sale of Esquire Financial common stock

Aggregate market value $127,303.30 Value of 10,000 ESQ shares to be sold under the notice

Shares outstanding 12,094,583 shares Esquire Financial common shares outstanding used for Rule 144 disclosure

RSA Stock Grant shares 298,798 shares Restricted Stock Award granted on December 16, 2024

Approximate sale date September 18, 2026 Target date for the planned sale of 10,000 shares

Key Terms

Rule 144, aggregate market value, shares outstanding, RSA Stock Grant

4 terms

Rule 144 regulatory

"notice under Rule 144 that Andrew C. Sagliocca plans to sell"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"lists an aggregate market value of $127,303.30 for these shares"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

shares outstanding financial

"with 12,094,583 shares outstanding and an approximate sale date"

Shares outstanding are the total number of a company’s stock units held by all shareholders, including institutional investors and company insiders — think of them as the total number of slices of the company’s ownership pie. Investors use this number to calculate how much of the company each share represents, and it directly affects per-share measures like earnings per share, ownership percentage and valuation; when the slice count changes, an investor’s claim and the company’s per-share metrics change too.

RSA Stock Grant financial

"The seller previously received an RSA Stock Grant of 298,798 shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for ESQ?

The filing discloses that Andrew C. Sagliocca plans to sell 10,000 shares of Esquire Financial Holdings, Inc. common stock under Rule 144, with an approximate sale date of September 18, 2026 and aggregate market value of $127,303.30.

How many ESQ shares are planned to be sold and when?

The notice states a planned sale of 10,000 shares of Esquire Financial’s common stock, with an approximate sale date of September 18, 2026, through Citigroup Global Markets Inc. as the broker.

What is the value of the ESQ shares covered by this Form 144?

The Form 144 lists an aggregate market value of $127,303.30 for the 10,000 Esquire Financial common shares to be sold, as reported in the securities information section.

How many ESQ shares are outstanding according to this filing?

The filing reports that there are 12,094,583 shares of Esquire Financial Holdings, Inc. common stock outstanding, which is used in the Rule 144 calculations and disclosure context.

What prior ESQ equity award to the seller is mentioned?

The filing notes an RSA Stock Grant from the issuer to Andrew C. Sagliocca dated December 16, 2024, covering 298,798 shares of common stock, described in the securities-to-be-sold section.

Which broker is involved in the planned ESQ share sale?

The Form 144 identifies Citigroup Global Markets Inc., located at 388 Greenwich Street, New York, NY, as the broker for the planned sale of 10,000 Esquire Financial common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/18/2026 - 03:39 PM Accepted by SEC EDGAR 09/18/2026 - 03:39 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001709867
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Esquire Financial Holdings, Inc.
SEC File Number	001-38131
Address of Issuer	100 JERICHO QUADRANGLE SUITE 100 JERICHO NEW YORK 11753
Phone	(800) 996-0213
Name of Person for Whose Account the Securities are To Be Sold	Sagliocca Andrew C
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Citigroup Global Markets Inc 388 Greenwich Street New York NY 10013	10000	127303.30	12094583	09/18/2026	JNST

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/16/2024	RSA Stock Grant	Issuer			298798	12/16/2024	RSA Grant

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew Sagliocca
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)